-
公开(公告)号:US20220031638A9
公开(公告)日:2022-02-03
申请号:US16626248
申请日:2017-06-30
申请人: JENIVISION INC.
发明人: Weizhen WANG , David F. WOODWARD
摘要: The present invention is directed to compositions and formulations for hair growth. The non-aqueous, preservative-free formulations are useful for the growth of hair, eyebrows and eyelash in a variety of setting. Also provided herein are non-aqueous, preservative-free formulations and methods for the treatment of dry-eye and related symptoms.
-
公开(公告)号:US20180008578A1
公开(公告)日:2018-01-11
申请号:US15710438
申请日:2017-09-20
申请人: JENIVISION INC.
IPC分类号: A61K31/4168 , A61K9/00
CPC分类号: A61K31/4168 , A61K9/0048 , A61K9/0051 , A61K31/195 , A61K31/21 , A61K31/343 , A61K31/404 , A61K31/421 , A61K31/4965 , A61K31/505 , A61K38/13 , A61K45/06 , A61K2300/00
摘要: The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
-
公开(公告)号:US20240165058A1
公开(公告)日:2024-05-23
申请号:US18492709
申请日:2023-10-23
申请人: JENIVISION INC.
发明人: Weizhen WANG , David F. WOODWARD
CPC分类号: A61K31/16 , A61K9/0014 , A61K47/10 , A61K47/44 , A61P17/14
摘要: The present invention is directed to compositions and formulations for hair growth. The non-aqueous, preservative-free formulations are useful for the growth of hair, eyebrows and eyelash in a variety of setting. Also provided herein are non-aqueous, preservative-free formulations and methods for the treatment of dry-eye and related symptoms.
-
公开(公告)号:US20240041832A1
公开(公告)日:2024-02-08
申请号:US18550907
申请日:2022-03-17
申请人: JENIVISION INC.
发明人: Weizhen WANG , David F. WOODWARD , Nonna SNIDER
IPC分类号: A61K31/4168 , A61K45/06 , A61K47/14 , A61K47/44 , A61K9/00 , A61K31/202
CPC分类号: A61K31/4168 , A61K45/06 , A61K47/14 , A61K47/44 , A61K9/0048 , A61K31/202
摘要: Described herein are compositions and methods for the topical administration of various compounds to the eye, in particular to the posterior portion of the eye. Such compositions and methods are useful for treating various disease and disorders, as well as in promoting the general health of the eye.
-
公开(公告)号:US20230372274A1
公开(公告)日:2023-11-23
申请号:US18363537
申请日:2023-08-01
申请人: JENIVISION INC.
发明人: Weizhen WANG , DAVID F. WOODWARD
IPC分类号: A61K31/216 , A61K9/00 , A61K47/14 , A61K9/06 , A61P27/06
CPC分类号: A61K31/216 , A61K9/0014 , A61K47/14 , A61K9/06 , A61P27/06
摘要: Described herein are compositions and methods for the topical administration of prodrugs of EP2 receptor agonists via the periorbital skin. Such compositions and methods are useful for treating various disease and disorders, including glaucoma.
-
公开(公告)号:US20170049734A1
公开(公告)日:2017-02-23
申请号:US14829789
申请日:2015-08-19
申请人: JENIVISION, INC.
发明人: David F. Woodward , Weizhen Wang
IPC分类号: A61K31/196 , A61K9/00
CPC分类号: A61K31/196 , A61K9/0048
摘要: The present invention is directed methods of lowering intraocular pressure in a patient suffering from elevated intraocular pressure or glaucoma and treating ocular disease by administering a drug to the periorbital skin of the patient.
摘要翻译: 本发明涉及通过向患者的眶周皮肤施用药物来降低患有眼内压升高或青光眼升高的患者眼内压的方法。
-
公开(公告)号:US20240350447A1
公开(公告)日:2024-10-24
申请号:US18687258
申请日:2022-11-23
申请人: JENIVISION INC.
发明人: Weizhen WANG , Nonna SNIDER
IPC分类号: A61K31/202 , A61K9/00 , A61K31/232 , A61K31/355 , A61K35/60 , A61K47/44
CPC分类号: A61K31/202 , A61K9/0014 , A61K9/0048 , A61K31/232 , A61K31/355 , A61K35/60 , A61K47/44
摘要: Described herein are compositions and methods for the topical administration of various compounds to the periorbital and eyelid region of the eye. Such compositions and methods are useful for treating various brain and central nervous system diseases and disorders, as well as in promoting general brain and central nervous system health.
-
公开(公告)号:US11857537B2
公开(公告)日:2024-01-02
申请号:US17210213
申请日:2021-03-23
申请人: JENIVISION INC.
IPC分类号: A61K31/4168 , A61K9/48 , A61K31/505 , A61K31/404 , A61K31/195 , A61K31/421 , A61K31/4965 , A61K45/06 , A61K31/343 , A61K31/21 , A61K38/13 , A61K9/00
CPC分类号: A61K31/4168 , A61K9/0048 , A61K9/0051 , A61K31/195 , A61K31/21 , A61K31/343 , A61K31/404 , A61K31/421 , A61K31/4965 , A61K31/505 , A61K38/13 , A61K45/06 , A61K31/4168 , A61K2300/00 , A61K31/4965 , A61K2300/00 , A61K31/421 , A61K2300/00 , A61K31/343 , A61K2300/00 , A61K31/505 , A61K2300/00 , A61K31/195 , A61K2300/00 , A61K31/404 , A61K2300/00 , A61K31/21 , A61K2300/00 , A61K38/13 , A61K2300/00
摘要: The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
-
公开(公告)号:US11478437B2
公开(公告)日:2022-10-25
申请号:US16626248
申请日:2017-06-30
申请人: JENIVISION INC.
发明人: Weizhen Wang , David F. Woodward
摘要: The present invention is directed to compositions and formulations for hair growth. The non-aqueous, preservative-free formulations are useful for the growth of hair, eyebrows and eyelash in a variety of setting. Also provided herein are non-aqueous, preservative-free formulations and methods for the treatment of dry-eye and related symptoms.
-
公开(公告)号:US20210212993A1
公开(公告)日:2021-07-15
申请号:US17210213
申请日:2021-03-23
申请人: JENIVISION INC.
IPC分类号: A61K31/4168 , A61K31/505 , A61K31/404 , A61K31/195 , A61K31/421 , A61K31/4965 , A61K45/06 , A61K31/343 , A61K31/21 , A61K38/13 , A61K9/00
摘要: The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
-
-
-
-
-
-
-
-
-